Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis
Authors:
Open Access
- 22 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 10, 815
Abstract
Osteoporosis and bone disorders related to the metabolic syndrome are often associated with adipokines secreted by adipocytes in bone. Adiponectin, a type of adipokine, is a regulator of immune responses and metabolic processes, but its role in bone biology remains uncertain. We investigated the role of adiponectin in bone metabolism using adiponectin-deficient mice in vivo and in vitro. Adiponectin-deficient mice exhibited reduced bone mass and increased adiposity. Adiponectin-deficient calvarial cells were prone to differentiate into adipocytes rather than osteoblasts. Although bone marrow macrophages (BMMs) from adiponectin-deficient mice had low osteoclastogenic potential as osteoclast precursors with increasing interferon regulatory factor 5 expression, under co-culture conditions of calvarial cells and BMMs, the enhanced receptor activator of nuclear factor κB ligand/osteoprotegerin (RANKL/OPG) ratio of adiponectin-deficient mesenchymal progenitor cells facilitated osteoclast differentiation. In addition, increased RANKL/OPG ratio was observed in the bone marrow extracellular fluid of adiponectin-deficient mice compared to that of wild-type mice. Notably, recombinant adiponectin treatment enhanced RANKL-induced osteoclast differentiation from BMMs but up-regulated OPG production in recombinant adiponectin-exposed calvarial cells, which inhibited osteoclast differentiation. Taken together, these results suggest that adiponectin plays an inhibitory role in bone metabolism through cross talk between precursor cells of both osteoclasts and osteoblasts by regulating RANKL/OPG ratio in the bone marrow microenvironment.Keywords
Funding Information
- National Research Foundation of Korea
This publication has 53 references indexed in Scilit:
- Adiponectin in inflammatory and immune-mediated diseasesCytokine, 2013
- The role of cytokines in inflammatory bone lossImmunological Investigations, 2013
- Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblastsWorld Journal of Stem Cells, 2013
- Hyperadiponectinemia enhances bone formation in miceBMC Musculoskeletal Disorders, 2011
- Adiponectin Promotes Macrophage Polarization toward an Anti-inflammatory PhenotypeJournal of Biological Chemistry, 2010
- Isolation of Mouse Peritoneal Cavity CellsJournal of Visualized Experiments, 2010
- Adiponectin Is a Negative Regulator of Bone Mineral and Bone Strength in Growing MiceExperimental Biology and Medicine, 2008
- Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1 −/− miceProceedings of the National Academy of Sciences, 2008
- Inhibition of osteoblast differentiation but not adipocyte differentiation of mesenchymal stem cells by sera obtained from aged femalesBone, 2006
- Adiponectin increases bone mass by suppressing osteoclast and activating osteoblastBiochemical and Biophysical Research Communications, 2005